Host Cells Upregulate Phosphate Transporter PIT1 to Inhibit Ehrlichia chaffeensis Intracellular Growth

Meifang Li1,2, Nan Yang1,2, Xiaoxiao Li1,2

  • 1The Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, Nankai University, Tianjin 300071, China.

Insights

Host cells combat Ehrlichia chaffeensis by upregulating phosphate transporter PIT1, which limits bacterial growth within vesicles. This innate immune response is triggered by the bacterial protein Ech_1067 via the MyD88-NF-κB pathway.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Microbiology

Background:

  • Human monocytic ehrlichiosis (HME) is a severe tick-borne zoonosis caused by Ehrlichia chaffeensis.
  • E. chaffeensis resides in host cell inclusions (ECVs) to evade immune responses and acquire nutrients.
  • Mechanisms by which host cells inhibit intracellular bacterial growth remain largely unknown.

Purpose of the Study:

  • To elucidate host cell mechanisms that restrict Ehrlichia chaffeensis proliferation.
  • To identify host factors involved in innate immunity against E. chaffeensis infection.
  • To understand the signaling pathway triggered by E. chaffeensis that modulates host defenses.

Main Methods:

  • Transcriptome sequencing, qRT-PCR, and Western blotting to identify host gene expression changes.
  • Confocal microscopy to determine the localization of PIT1 in infected cells.
  • RNA interference (shRNA and siRNA) and recombinant protein stimulation to investigate molecular pathways.

Main Results:

  • Host cells upregulate the phosphate transporter PIT1 upon E. chaffeensis infection.
  • PIT1 localizes to the ECV membrane and its depletion enhances bacterial growth.
  • E. chaffeensis Ech_1067 protein induces PIT1 upregulation via the MyD88-NF-κB pathway.

Conclusions:

  • Host cells utilize PIT1 to limit intracellular E. chaffeensis growth, representing a novel innate immune mechanism.
  • The bacterial protein Ech_1067 activates the MyD88-NF-κB pathway to induce PIT1 expression.
  • Findings provide insights into HME pathogenesis and potential therapeutic targets.